AstraZeneca AZN.L on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus.
AstraZeneca says it will prioritize U.S. market for RSV drug
© The Crystal Eyes
AstraZeneca AZN.L on Friday said it was prioritizing the U.S. market for additional doses of its respiratory syncytial virus (RSV) drug Beyfortus.
© The Crystal Eyes